The Sabin Vaccine Institute (Sabin) and its UK sister organization Sabin Foundation Europe, released the following statement on the UK government’s allocation of £1 billion for malaria and other infectious diseases. This funding will be distributed through the newly-developed Ross Fund, created by the Department for International Development (DFID) in collaboration with the Bill and Melinda Gates Foundation.
WASHINGTON, D.C. — November 16, 2015 — The Sabin Vaccine Institute Product Development Partnership (Sabin PDP) today signed a project agreement with King Saud University to build vaccine research and development capacity in the Middle East and North Africa (MENA) region and advance the establishment of a vaccine research institute in Saudi Arabia.
WASHINGTON, D.C. — November 10, 2015 — The Sabin Vaccine Institute (Sabin) today announced that Regina Rabinovich, M.D., M.P.H., has joined its Board of Trustees.
RIO DE JANEIRO, BRAZIL — November 3, 2015 — More than one hundred public health experts and stakeholders gathered today in Rio de Janeiro, Brazil, for the First Regional Dengue Symposium, led by the Pan American Health Organization (PAHO), the Sabin Vaccine Institute (Sabin) and the Dengue Vaccine Initiative (DVI).